Ian R Reid Selected Research

Infections

5/2012	Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART).
11/2011	Epidemiology and pathogenesis of osteonecrosis of the jaw.
1/2009	Osteonecrosis of the jaw: who gets it, and why?
1/2008	Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
8/2007	Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian R Reid Research Topics

Disease

67	Osteoporosis 12/2022 - 02/2002
23	Bone Resorption 01/2022 - 02/2002
18	Myocardial Infarction 04/2020 - 02/2008
16	Neoplasms (Cancer) 10/2020 - 07/2003
14	Postmenopausal Osteoporosis 12/2019 - 02/2002
12	Metabolic Bone Diseases (Osteopenia) 01/2020 - 02/2002
11	Stroke (Strokes) 01/2020 - 02/2008
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 01/2004
10	Body Weight (Weight, Body) 01/2020 - 06/2003
9	Osteitis Deformans (Paget's Disease of Bone) 01/2017 - 07/2004
6	Kidney Calculi (Kidney Stone) 01/2021 - 08/2010
6	Hip Fractures (Intertrochanteric Fractures) 01/2021 - 01/2002
6	Gout 01/2021 - 06/2008
6	Osteonecrosis (Kienbock's Disease) 01/2017 - 11/2006
5	Infections 05/2012 - 08/2007
4	Constipation 04/2020 - 09/2006
4	Vitamin D Deficiency 11/2019 - 02/2012
4	Osteomalacia 01/2018 - 07/2015
3	Acute-Phase Reaction 01/2022 - 12/2013
3	Vascular Calcification 10/2020 - 12/2010
3	Breast Neoplasms (Breast Cancer) 11/2019 - 07/2003
3	Vascular Diseases (Vascular Disease) 09/2017 - 12/2010
3	Insulin Resistance 06/2013 - 04/2007
3	Hypertension (High Blood Pressure) 03/2013 - 04/2005
3	Pain (Aches) 06/2012 - 07/2008
3	Primary Hyperparathyroidism 07/2008 - 04/2005
2	Osteoarthritis 01/2021 - 12/2014
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 10/2011
2	Sudden Death 01/2020 - 02/2008
2	Heart Neoplasms 01/2020 - 01/2010
2	Atrial Fibrillation 12/2019 - 05/2007
2	Disease Progression 01/2019 - 07/2008
2	Anterior Uveitis 07/2015 - 04/2013
2	Secondary Hyperparathyroidism 02/2009 - 12/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 01/2009
1	Femoral Fractures (Femoral Fracture) 12/2022
1	Chronic Renal Insufficiency 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Hyperuricemia 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Headache (Headaches) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Renal Insufficiency (Renal Failure) 09/2017

Drug/Important Bio-Agent (IBA)

39	CalciumIBA 01/2022 - 04/2002
32	Zoledronic Acid (Zometa)FDA Link 01/2022 - 02/2002
31	Diphosphonates (Bisphosphonates)IBA 12/2022 - 02/2002
24	Vitamin D FDA LinkGeneric 08/2020 - 04/2005
14	Denosumab FDA Link 01/2020 - 08/2009
6	Pharmaceutical PreparationsIBA 12/2022 - 01/2009
5	Biomarkers (Surrogate Marker)IBA 10/2013 - 02/2002
4	collagen type I trimeric cross-linked peptideIBA 01/2022 - 04/2007
4	GlucocorticoidsIBA 01/2018 - 04/2005
4	MineralsIBA 01/2017 - 03/2009
4	25-hydroxyvitamin DIBA 02/2016 - 08/2007
3	Hormones (Hormone)IBA 01/2022 - 06/2013
3	romosozumabIBA 01/2022 - 08/2017
3	Estrogens (Estrogen)FDA Link 01/2020 - 04/2005
3	Cathepsin KIBA 12/2019 - 03/2005
3	Monoclonal AntibodiesIBA 01/2018 - 08/2009
3	Uric Acid (Urate)IBA 01/2018 - 06/2008
3	Calcium-Sensing ReceptorsIBA 09/2017 - 03/2005
3	Phosphates (Orthophosphate)IBA 07/2017 - 03/2006
3	Parathyroid Hormone (Parathormone)IBA 01/2016 - 03/2006
3	Alkaline PhosphataseIBA 12/2014 - 09/2006
3	Procollagen Type IIBA 11/2014 - 09/2006
2	hydroxide ionIBA 01/2020 - 01/2010
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2020 - 06/2013
2	odanacatibIBA 12/2019 - 02/2011
2	Bone Density Conservation AgentsIBA 11/2019 - 08/2013
2	Dietary CalciumIBA 01/2019 - 03/2006
2	LeptinIBA 12/2018 - 06/2003
2	Anabolic AgentsIBA 12/2018 - 03/2005
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2008
2	Teriparatide (Parathar)FDA Link 01/2017 - 01/2016
2	OsteoprotegerinIBA 02/2016 - 09/2002
2	Glucose (Dextrose)FDA LinkGeneric 06/2013 - 01/2010
2	FluoridesIBA 06/2013 - 07/2007
2	AcidsIBA 03/2011 - 06/2003
2	LipidsIBA 01/2010 - 01/2004
2	CholesterolIBA 01/2010 - 01/2004
2	RANK LigandIBA 08/2009 - 03/2005
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2008 - 04/2004
2	LactoferrinIBA 05/2005 - 09/2004
2	Peptides (Polypeptides)IBA 05/2004 - 06/2003
1	Inosine FDA Link 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2020
1	NitratesIBA 01/2020
1	TabletsIBA 01/2020
1	Fibroblast Growth Factor-23IBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2018

Therapy/Procedure

34	Therapeutics 01/2022 - 04/2002
3	Drug Therapy (Chemotherapy) 12/2022 - 05/2002
3	Highly Active Antiretroviral Therapy (HAART) 05/2012 - 08/2006
2	Oral Surgery (Maxillofacial Surgery) 01/2017 - 01/2015
2	Intravenous Infusions 07/2015 - 01/2008
2	Dentures 01/2015 - 09/2007
2	Fracture Fixation 06/2013 - 03/2011
1	Replacement Arthroplasty 01/2021